The closing price of Emergent Biosolutions Inc (NYSE: EBS) was $2.69 for the day, down -2.89% from the previous closing price of $2.77. In other words, the price has decreased by -$0.0800 from its previous closing price. On the day, 1835897 shares were traded.
Ratios:
Our analysis of EBS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.54 and its Current Ratio is at 1.04. In the meantime, Its Debt-to-Equity ratio is 1.32 whereas as Long-Term Debt/Eq ratio is at 0.69.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 02 ’23 when Zoon Kathryn C sold 1,830 shares for $8.35 per share. The transaction valued at 15,280 led to the insider holds 49,971 shares of the business.
Zoon Kathryn C sold 1,700 shares of EBS for $14,246 on May 25 ’23. The Director now owns 51,801 shares after completing the transaction at $8.38 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 140.42M and an Enterprise Value of 914.42M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.13 while its Price-to-Book (P/B) ratio in mrq is 0.22. Its current Enterprise Value per Revenue stands at 0.85 whereas that against EBITDA is -1.72.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $13.67, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is 2.2038, while the 200-Day Moving Average is calculated to be 4.1359.
Shares Statistics:
EBS traded an average of 3.09M shares per day over the past three months and 3.31M shares per day over the past ten days. A total of 52.20M shares are outstanding, with a floating share count of 49.77M. Insiders hold about 4.08% of the company’s shares, while institutions hold 79.35% stake in the company. Shares short for EBS as of Feb 15, 2024 were 11.54M with a Short Ratio of 3.73, compared to 11.82M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 22.23% and a Short% of Float of 36.82%.
Earnings Estimates
The firm’s stock currently is rated by 2 analysts. On average, analysts expect EPS of -$0.62 for the current quarter, with a high estimate of -$0.41 and a low estimate of -$0.83, while EPS last year was -$3.17. The consensus estimate for the next quarter is -$0.74, with high estimates of -$0.63 and low estimates of -$0.86.
Analysts are recommending an EPS of between $2.51 and -$2 for the fiscal current year, implying an average EPS of $0.25. EPS for the following year is $3.67, with 1 analysts recommending between $3.67 and $3.67.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for EBS’s current fiscal year. The highest revenue estimate was $1.17B, while the lowest revenue estimate was $1.02B, resulting in an average revenue estimate of $1.1B. In the same quarter a year ago, actual revenue was $1.05B, up 4.70% from the average estimate. Based on 1 analysts’ estimates, the company’s revenue will be $1.13B in the next fiscal year. The high estimate is $1.13B and the low estimate is $1.13B. The average revenue growth estimate for next year is up 2.50% from the average revenue estimate for this year.
